By Dr. Liji Thomas, MD May 19 2021 Reviewed by Emily Henderson, B.Sc. With the controversy surrounding the dosing interval for the Oxford Astra-Zeneca vaccine against coronavirus disease 2019 (COVID-19), a new preprint published on the pre-print server medRxiv* discusses the results of a study of antibody responses to the first and second dose of two currently...
